[1] Mehal WZ.The gut-liver axis:A busy two-way street.Hepatology,2012,55:1647-1649. [2] 王春妍,杨世忠,江海艳. 急性肝损伤大鼠肠源性内毒素血症形成机理及其作用的实验研究.临床肝胆病杂志,2007,23:109-111 [3] Bures J,Cyrany J,Kohoutova D,et al.Small intestinal bacterial overgrowth syndrome.World J Gastroenterol,2010,16:2978-2990. [4] Casafunt Morencos F,de las Heras Castafio G,Martin Ramos L,et al.Small bowel bacterial overgrowth in patients with alcoholic cirrhosis.Dig Dis Sci,1996,41:552-556. [5] Paolella G,Mandato C,Pierri L,et al.Gut-liver axis and probiotics:their role in non-alcoholic fatty liver disease.WorId JGastroenterol,2014,20:15518-15531. [6] Mariat D,Firmesse O,Levenez F,et al.The Firmicutes/Bacteroidetes ratio of the human microbiot a changes with age.BMC Microbiol,2009,9:123. [7] Ley RE,Turnbaugh PJ ,Klein S,et al.Microbial ecology:human gut microbes associated with obesity.Nature,2006,444:1022-1023. [8] Kuugbee ED,Shang X,Gamallaty Y,et al. Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and ReducesCancer via TLR2 Signaling in a Rat Model of Colon Cancer.Dig Dis Sci,2016:2908-2920. [9] Dolpady J, Sorini C, Di Pietro C,et al.Oral probiotic VSL#3 prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2,3-dioxygenase-enriched tolerogenic intestinal environment.J Diabetes Res,2016:7569431. [10] Wang J,Tang H,Zhang C,et al.Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice.ISME J,2015:1-15. [11] Rauch M,Lyngh SV.Probiotic manipulation of the gastroin-testinal microbiota.Gut Microbes,2010:335-338. |